Fresenius Medical Care Ag (FMS)

$20.29

-0.1

(-0.49%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $20.14
    $20.43
    $20.29
    downward going graph

    0.74%

    Downside

    Day's Volatility :1.42%

    Upside

    0.69%

    downward going graph
  • $15.91
    $25.95
    $20.29
    downward going graph

    21.59%

    Downside

    52 Weeks Volatility :38.69%

    Upside

    21.81%

    downward going graph

Returns

PeriodFresenius Medical Care AgSector (Health Care)Index (Russel 2000)
3 Months
1.44%
6.5%
0.0%
6 Months
1.59%
7.1%
0.0%
1 Year
-22.77%
9.8%
0.0%
3 Years
-49.63%
14.2%
-20.2%

Highlights

Market Capitalization
11.9B
Book Value
$47.4
Dividend Share
1.19
Dividend Yield
3.19%
Earnings Per Share (EPS)
0.9
PE Ratio
22.58
PEG Ratio
0.39
Wall Street Target Price
19.52
Profit Margin
2.48%
Operating Margin TTM
7.65%
Return On Assets TTM
2.83%
Return On Equity TTM
4.72%
Revenue TTM
19.5B
Revenue Per Share TTM
33.19
Quarterly Revenue Growth YOY
0.4%
Gross Profit TTM
5.3B
EBITDA
2.5B
Diluted Eps TTM
0.9
Quarterly Earnings Growth YOY
-0.17
EPS Estimate Current Year
1.5
EPS Estimate Next Year
1.95
EPS Estimate Current Quarter
0.26
EPS Estimate Next Quarter
0.37

Analyst Recommendation

Hold
    14%Buy
    53%Hold
    32%Sell
Based on 28 Wall street analysts offering stock ratings for Fresenius Medical Care Ag(by analysts ranked 0 to 5 stars)
Based on 28 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
5
Hold
15
15
15
Sell
9
9
9

Analyst Forecast

What analysts predicted

Downside of 3.79%

Current $20.29
Target $19.52

Company Financials

FY18Y/Y Change
Revenue
18.9B
↓ 6.96%
Net Income
2.3B
↑ 54.84%
Net Profit Margin
11.98%
↑ 4.78%
FY19Y/Y Change
Revenue
19.6B
↑ 5.62%
Net Income
1.3B
↓ 39.46%
Net Profit Margin
6.87%
↓ 5.11%
FY20Y/Y Change
Revenue
22.0B
↑ 2.19%
Net Income
1.4B
↓ 2.97%
Net Profit Margin
6.52%
↓ 0.35%
FY21Y/Y Change
Revenue
20.0B
↓ 1.34%
Net Income
1.1B
↓ 16.75%
Net Profit Margin
5.5%
↓ 1.02%
FY22Y/Y Change
Revenue
20.8B
↑ 10.1%
Net Income
721.4M
↓ 30.53%
Net Profit Margin
3.47%
↓ 2.03%
FY23Y/Y Change
Revenue
19.5B
↑ 0.29%
Net Income
499.0M
↓ 25.9%
Net Profit Margin
2.57%
↓ 0.9%
Q4 FY22Q/Q Change
Revenue
5.4B
↓ 1.95%
Net Income
207.8M
↓ 15.69%
Net Profit Margin
3.88%
↓ 0.64%
Q1 FY23Q/Q Change
Revenue
5.1B
↓ 5.86%
Net Income
146.0M
↓ 31.0%
Net Profit Margin
2.85%
↓ 1.03%
Q2 FY23Q/Q Change
Revenue
5.3B
↑ 2.57%
Net Income
153.1M
↑ 4.86%
Net Profit Margin
2.91%
↑ 0.06%
Q3 FY23Q/Q Change
Revenue
4.9B
↑ 2.3%
Net Income
84.4M
↓ 39.9%
Net Profit Margin
1.71%
↓ 1.2%
Q4 FY23Q/Q Change
Revenue
5.0B
↑ 1.05%
Net Income
187.9M
↑ 122.79%
Net Profit Margin
3.77%
↑ 2.06%
Q1 FY24Q/Q Change
Revenue
5.1B
↓ 5.27%
Net Income
76.6M
↓ 62.24%
Net Profit Margin
1.5%
↓ 2.27%
FY18Y/Y Change
Total Assets
30.0B
↑ 9.23%
Total Liabilities
15.3B
↑ 1.08%
FY19Y/Y Change
Total Assets
36.9B
↑ 25.5%
Total Liabilities
22.1B
↑ 47.74%
FY20Y/Y Change
Total Assets
39.0B
↓ 3.78%
Total Liabilities
23.8B
↓ 1.78%
FY21Y/Y Change
Total Assets
38.9B
↑ 8.45%
Total Liabilities
23.1B
↑ 5.32%
FY22Y/Y Change
Total Assets
38.3B
↑ 4.04%
Total Liabilities
21.8B
↓ 0.41%
FY23Y/Y Change
Total Assets
33.9B
↓ 5.1%
Total Liabilities
19.1B
↓ 5.92%
Q4 FY22Q/Q Change
Total Assets
38.3B
↓ 6.91%
Total Liabilities
21.8B
↓ 6.3%
Q1 FY23Q/Q Change
Total Assets
38.1B
↓ 2.22%
Total Liabilities
21.8B
↓ 1.35%
Q2 FY23Q/Q Change
Total Assets
38.1B
↑ 0.0%
Total Liabilities
21.9B
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
35.6B
↑ 1.93%
Total Liabilities
20.2B
↑ 0.85%
Q4 FY23Q/Q Change
Total Assets
33.9B
↓ 4.78%
Total Liabilities
19.1B
↓ 5.43%
Q1 FY24Q/Q Change
Total Assets
37.1B
↑ 1.2%
Total Liabilities
20.7B
↑ 0.53%
FY18Y/Y Change
Operating Cash Flow
2.4B
↓ 5.93%
Investing Cash Flow
-280.3M
↓ 75.29%
Financing Cash Flow
-779.9M
↓ 14.64%
FY19Y/Y Change
Operating Cash Flow
2.9B
↑ 24.49%
Investing Cash Flow
-3.7B
↑ 1241.01%
Financing Cash Flow
-522.7M
↓ 31.55%
FY20Y/Y Change
Operating Cash Flow
5.2B
↑ 64.9%
Investing Cash Flow
-1.6B
↓ 59.37%
Financing Cash Flow
-3.3B
↑ 470.9%
FY21Y/Y Change
Operating Cash Flow
2.8B
↓ 41.2%
Investing Cash Flow
-1.4B
↓ 10.39%
Financing Cash Flow
-1.2B
↓ 61.55%
FY22Y/Y Change
Operating Cash Flow
2.3B
↓ 12.94%
Investing Cash Flow
-787.1M
↓ 38.58%
Financing Cash Flow
-1.7B
↑ 57.89%
Q4 FY22Q/Q Change
Operating Cash Flow
642.7M
↓ 8.76%
Investing Cash Flow
-787.1M
↑ 628.95%
Financing Cash Flow
-128.5M
↓ 76.14%
Q1 FY23Q/Q Change
Operating Cash Flow
155.8M
↓ 76.19%
Investing Cash Flow
-178.1M
↓ 77.78%
Financing Cash Flow
2.2M
↓ 101.68%
Q2 FY23Q/Q Change
Operating Cash Flow
1.1B
↑ 605.11%
Investing Cash Flow
-323.6M
↑ 81.67%
Financing Cash Flow
-766.6M
↓ 34983.76%
Q3 FY23Q/Q Change
Operating Cash Flow
759.8M
↓ 24.56%
Investing Cash Flow
-447.7M
↑ 50.94%
Financing Cash Flow
-412.3M
↓ 41.31%

Technicals Summary

Sell

Neutral

Buy

Fresenius Medical Care Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Fresenius Medical Care Ag

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 4.98B → 4.72B (in $), with an average decrease of 5.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 187.92M → 70.95M (in $), with an average decrease of 62.2% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 117.9%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 108.9% return, outperforming this stock by 158.5%

Institutional Holdings

  • Pzena Investment Management, LLC

    2.77%
  • Fiduciary Management, Inc. of Milwaukee

    0.92%
  • Dodge & Cox

    0.72%
  • Morgan Stanley - Brokerage Accounts

    0.17%
  • Goldman Sachs Group Inc

    0.11%
  • Pacer Advisors, INC.

    0.08%

Corporate Announcements

  • Fresenius Medical Care Ag Dividends September,2024

    In the quarter ending September,2024. Fresenius Medical Care Ag has declared dividend of $0.63

    Read More

Company Information

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

Organization
Fresenius Medical Care Ag
Employees
117128
CEO
Ms. Helen Giza
Industry
Health Services

FAQs